Option chain shows key data for Clene's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Clene.

Clene (NASDAQ:CLNN) Stock, Option Chain

Clene

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AVGO

BLMZ

BOWL

CLNN

EAST

FFIE

GWRE

HOTH

SIFY

SWBI

TDUP

WHLR

Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Gold bar and nugget

Earnings

Eurozone

Commodities

Intraday Update

BDRX

ETWO

Gold Rises Sharply; Methode Electronics Shares Spike Higher

Indianapolis,-,Circa,July,2019:,Conagra,Brands,Manufacturing,Plant.,Conagra

ASNS

ASTH

BRCC

BSFC

CGBS

CING

IGMS

ISPC

KZIA

LGVN

LNTH

LUCY

MSTR

NAAS

OKYO

POOL

QURE

RBBN

RNLX

SOUN

TBIO

TERN

VLCN

VRPX

Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Clene Inc

Health Care

Press Releases

Clene and APST Enter Into an Agreement to Support FDA's Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®'s Impact on NfL Reduction

Events

Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11

Clene to Present at the 37TH Annual Roth Conference

Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment

Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights

Clene to Present at the Jones Healthcare and Technology Innovation Conference

General

Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session

Clene to Present at the Emerging Growth Conference

Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

ASBP

BENF

BIXT

BNZI

CSE:HG

CUAUF

CYIO

ELRRF

EVFM

GOVX

HGRAF

OMEX

OPWEF

PSQH

RGBP

SEVCF

TSX:ELO

TSX:URE

TSXV:CCCM

TSXV:OPW

TSXV:UCU

USEG

UURAF

XXII

Allakos

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Annovis Bio

BioAtla

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

CEL-SCI

Elevation Oncology

FibroGen

Generation Bio

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

MiNK Therapeutics

Longeveron

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

Lisata Therapeutics

Nanoviricides

OSR Holdings

Ovid Therapeutics

Passage Bio

Q32 Bio

Tenax Therapeutics

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

Jones Trading

D. Boral Capital

HC Wainwright & Co.

Benchmark

Canaccord Genuity

Comments

Clene

Clene (CLNN) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell